Latest News & Features
Americas
China-based pharmaceutical technology company WuXi AppTec has partnered with artificial intelligence specialist Insilico Medicine to integrate Insilico’s AI technology with WuXi’s laboratory infrastructure. 13 June 2018
Americas
An Indiana district court did not abuse its discretion in denying attorneys’ fees to medical device company Cook Medical, the US Court of Appeals for the Federal Circuit said yesterday in a precedential decision. 12 June 2018
Americas
Drug makers Takeda and Lundbeck have filed a patent infringement lawsuit over anti-depressant medication Trintellix (vortioxetine hydrobromide), less than a month after launching similar claims. 12 June 2018
Americas
The US Federal Trade Commission has filed an amicus brief urging a district court to reject Takeda’s claim that its patent infringement lawsuit brought under the Hatch-Waxman Act cannot be a sham. 11 June 2018
Big Pharma
The European Commission has proposed that the next long-term EU budget (2021-2027) includes €100 billion ($117.55 billion) for research and innovation, in what it calls the most ambitious such programme yet. 8 June 2018
Americas
“The Saint Regis Mohawk Tribe issue is not unique to just life sciences—we’re likely to see it across the board. There’s likely been other transfers that are not yet public information,” said Teresa Rea, vice-chair of Crowell & Moring’s IP group and former director of the US Patent and Trademark Office. 8 June 2018
Generics
Sometimes the pharmaceutical industry is putting in place barriers to generic makers’ ability to get access to and samples of drugs, according to Scott Gottlieb, commissioner of the US Food and Drug Administration. 8 June 2018
Americas
Pharmaceutical company Astellas Pharma has filed a patent infringement claim against India-based Cipla over a drug for treating an overactive bladder. 7 June 2018
Americas
German life sciences company Bayer has completed the $66 billion buyout of agricultural corporation Monsanto, a week after the US government announced Bayer must divest $9 billion worth of assets for the deal to proceed. 7 June 2018
Americas
Private capital must finance the life sciences industry in the US otherwise the country will lose its advantage in the life sciences field, claimed Jonathan Kraft, president of The Kraft Group. 7 June 2018